Safety and efficacy of long-term asenapine versus olanzapine in schizophrenia or schizoaffective disorder patients

被引：0
|
作者：
Schoemaker, J.
Stet, L.
Naber, D.
Panagides, J.
Emsley, R.
机构：
来源：
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY | 2010年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：238 / 238
页数：1
相关论文
共 50 条
  • [1] SAFETY AND EFFICACY OF LONG-TERM ASENAPINE VERSUS OLANZAPINE IN SCHIZOPHRENIA OR SCHIZOAFFECTIVE DISORDER PATIENTS
    Schoemaker, J.
    Naber, D.
    Jansen, W.
    Panagides, J.
    Emsley, R.
    EUROPEAN PSYCHIATRY, 2010, 25
  • [2] Long-Term Efficacy and Safety of Asenapine or Olanzapine in Patients with Schizophrenia or Schizoaffective Disorder: An Extension Study
    Schoemaker, J.
    Stet, L.
    Vrijland, P.
    Naber, D.
    Panagides, J.
    Emsley, R.
    PHARMACOPSYCHIATRY, 2012, 45 (05) : 196 - 203
  • [3] Long-Term Assessment of Asenapine vs. Olanzapine in Patients with Schizophrenia or Schizoaffective Disorder
    Schoemaker, J.
    Naber, D.
    Vrijland, P.
    Panagides, J.
    Emsley, R.
    PHARMACOPSYCHIATRY, 2010, 43 (04) : 138 - 146
  • [4] Long-Term Assessment of Asenapine vs. Olanzapine in Patients with Schizophrenia or Schizoaffective Disorder (vol 43, pg 138, 2010)
    Schoemaker, J.
    Naber, D.
    Vrijland, P.
    Panagides, J.
    Emsley, R.
    PHARMACOPSYCHIATRY, 2011, 44 (07) : 343 - 343
  • [5] Safety and efficacy of olanzapine long-acting injection for up to 6 years in patients with schizophrenia or schizoaffective disorder
    McDonnell, D. P.
    Detke, H. C.
    Choukour, M.
    Landry, J.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2012, 22 : S319 - S320
  • [6] Risperidone versus olanzapine in the treatment of patients with schizophrenia or schizoaffective disorder
    Brecher, M
    SCHIZOPHRENIA RESEARCH, 1999, 36 (1-3) : 271 - 271
  • [7] Olanzapine versus haloperidol in the treatment of schizoaffective disorder - Acute and long-term therapy
    Tran, PV
    Tollefson, GD
    Sanger, TM
    Lu, YL
    Berg, PH
    Beasley, CM
    BRITISH JOURNAL OF PSYCHIATRY, 1999, 174 : 15 - 22
  • [8] Risperidone versus olanzapine in schizophrenia or schizoaffective disorder
    Conley, R
    Brecher, M
    BIOLOGICAL PSYCHIATRY, 1999, 45 (08) : 37S - 37S
  • [9] Long-term efficacy and safety of aripiprazole in patients with schizophrenia, schizophreniform disorder, or schizoaffective disorder: 26-week prospective study
    Kwon, Jun Soo
    Jang, Joon Hwan
    Kang, Do-Hyung
    Yoo, So Young
    Kim, Yong Ku
    Cho, Seong-Jin
    PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2009, 63 (01) : 73 - 81
  • [10] Long-term safety and tolerability of long-acting injectable risperidone in patients with schizophrenia or schizoaffective disorder
    Lindenmayer, Jean-Pierre
    Khan, Akbar
    Eerdekens, Marielle
    Van Hove, Ilse
    Kushner, Stuart
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2007, 17 (02) : 138 - 144
12345